InvestorsHub Logo

ManicTrader

04/20/11 12:56 AM

#290 RE: ManicTrader #288

$NFRM is pleased to obtain the exclusive license to the technology on worldwide basis for GLB333. The product that has considerable data already, will be ready for clinical trials Phase I/II in near future," said Elaine Affleck, President of National Pharmaceuticals Corp. http://t.co/6g3n3KI 03/22/11

ManicTrader

04/20/11 12:57 AM

#294 RE: ManicTrader #288

Compensated Awareness Post View Disclaimer
$NFRM news Mar 18, 2011 http://t.co/U6cU1E3